Neuroinflammation as Cause vs Consequence in Neurodegeneration
📖 Wiki Page
mechanism997 wordssynced 2026-04-02
Neuroinflammation as Cause vs Consequence in Neurodegeneration
Overview
The role of neuroinflammation in neurodegenerative diseases remains one of the most debated topics in neuroscience. This debate centers on whether chronic neuroinflammation is a primary driver of pathology (causing neuronal dysfunction and death) or a secondary response to other insults (consequence of underlying disease processes). Understanding this distinction has profound implications for therapeutic strategies. [@heneka2015]
The Two Perspectives
flowchart TD
subgraph CAUSE ["Neuroinflammation as Primary Cause"]
A["Genetic/Environmental Risk"] --> B["Microglial Activation"]
B --> C["Chronic Neuroinflammation"]
C --> D["Synaptic Pruning Dysregulation"]
D --> E["Neuronal Dysfunction"]
E --> F["Protein Aggregation"]
F --> G["Cognitive Decline"]
end
subgraph CONSEQUENCE ["Neuroinflammation as Secondary Response"]
H["Primary Insult"] --> IAbeta/T["au Pathology"]
I --> J["Damaged Neurons"]
J --> K["Reactive Microgliosis"]
K --> L"Neuroinflammation"
L --> M"Excitotoxicity"
M --> N["Accelerated Neurodegeneration"]
end
style CAUSE fill:#3b1114,color:#e0e0e0
style CONSEQUENCE fill:#0e2e10,color:#e0e0e0
Neuroinflammation as Cause
...
Neuroinflammation as Cause vs Consequence in Neurodegeneration
Overview
The role of neuroinflammation in neurodegenerative diseases remains one of the most debated topics in neuroscience. This debate centers on whether chronic neuroinflammation is a primary driver of pathology (causing neuronal dysfunction and death) or a secondary response to other insults (consequence of underlying disease processes). Understanding this distinction has profound implications for therapeutic strategies. [@heneka2015]
The Two Perspectives
Mermaid diagram (expand to render)
Neuroinflammation as Cause
The neuroinflammation-as-cause model proposes that chronic activation of brain immune cells (primarily [microglia](/cell-types/microglia-neuroinflammation) and astrocytes) initiates or dramatically accelerates neurodegeneration: [@griciuc2021]
Microglial priming: Genetic variants ([TREM2](/proteins/trem2), CR1, CLU) or environmental factors prime microglia
Chronic activation: Sustained inflammatory responses without resolution
The neuroinflammation-as-consequence model argues that neuroinflammation is a protective response that becomes dysregulated secondarily: [@kaufman2022]
Primary insult: Aβ plaques, tau tangles, or other pathology
The neuroinflammation cause vs consequence debate has evolved to recognize the complex, bidirectional relationship between immune activation and neurodegeneration:
Both models have merit depending on disease stage and individual
Genetic predisposition (TREM2, etc.) supports causal role in some cases
Vicious cycles make it impossible to separate cause from consequence
Precision targeting of specific inflammatory pathways may succeed where broad anti-inflammatory approaches failed
The future of neuroinflammation research lies in:
Timing-specific interventions (preventive vs therapeutic)
Leite-Aguiar R et al. (2026 May 1) [Extracellular nucleotides mediate viral central nervous system infections: Key alarmins of neuroinflammation and neurodegeneration.](https://pubmed.ncbi.nlm.nih.gov/40364625/). Neural Regen Res*
Singh AS et al. (2026 Apr) [Microglial, astrocytic, oligodendrocyte, B-/T-cell and neutrophil dysregulation in neuroinflammation of Alzheimer's disease and related dementias.](https://pubmed.ncbi.nlm.nih.gov/41637998/). J Psychiatr Res*
Eltarzy MA et al. (2026 Apr) [From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease.](https://pubmed.ncbi.nlm.nih.gov/41591821/). Drug Dev Res*
Alanazi M et al. (2026 Apr) [Targeting of PCSK9 in the Management of Alzheimer's Disease: Expanding the New Potential Key Player.](https://pubmed.ncbi.nlm.nih.gov/41549952/). Drug Dev Res*
Del Campo-Montoya R et al. (2026 Apr 1) [Targeting neuroinflammation in Parkinson's disease: Immunomodulatory effects of a hyaluronic acid-based nanoreinforced hydrogel loaded with GDNF and mesenchymal stem cells.](https://pubmed.ncbi.nlm.nih.gov/41205932/). Eur J Pharm Sci*